Evaluation of efficacy of natural astaxanthin and vitamin E in prevention of colistin-induced nephrotoxicity in the rat model

Environmental Toxicology and Pharmacology

Volumn 37, Issue 3, 2014, Pages 960-966

  Ghlissi, Zohra ^a   Hakim, Ahmed ^a   Sila, Assaad ^b   Mnif, Hela ^c   Zeghal, Khaled ^a   Rebai, Tarek ^a   Bougatef, Ali ^b   Sahnoun, Zouheir ^a  

^a UNIVERSITY OF SFAX   (Tunisia)

^b UNIVERSITY OF SFAX   (Tunisia)

^c HABIB BOURGUIBA HOSPITAL   (Tunisia)

Author keywords

Astaxanthin; Colistin; Nephrotoxicity; Oxidative damage; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ASTAXANTHIN; CATALASE; CREATININE; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; MALONALDEHYDE; SUPEROXIDE DISMUTASE; ANTIINFECTIVE AGENT; ANTIOXIDANT; COLISTIN; XANTHOPHYLL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; DRUG EFFICACY; DRUG SCREENING; ENZYME ACTIVITY; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HISTOPATHOLOGY; KIDNEY PARENCHYMA; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; RENAL PROTECTION; TREATMENT DURATION; ANIMAL; BLOOD; CHEMICALLY INDUCED; DRUG EFFECTS; KIDNEY; KIDNEY DISEASES; METABOLISM; PATHOLOGY; URINE; WISTAR RAT;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIOXIDANTS; CATALASE; COLISTIN; CREATININE; GAMMA-GLUTAMYLTRANSFERASE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; KIDNEY; KIDNEY DISEASES; MALE; MALONDIALDEHYDE; RATS, WISTAR; SUPEROXIDE DISMUTASE; VITAMIN E; XANTHOPHYLLS;

EID: 84897931994     PISSN: 13826689     EISSN: 18727077     Source Type: Journal    
DOI: 10.1016/j.etap.2014.03.004     Document Type: Article

References (40)

1. Abdel-Naim A.B., Abdel-Wahab M.H., Attia F.F. Protective effects of vitamin E and probucol against gentamicin-induced nephrotoxicity in rats. Pharm. Res. 1999, 40:183-187.
2. Aebi H. Catalase in vitro. Methods Enzymol. 1984, 105:121-126.
3. Ajith T.A., Usha S., Nivitha V. Ascorbic acid and alpha-tocopherol protect anticancer drug cisplatin induced nephrotoxicity in mice: a comparative study. Clin. Chim. Acta 2007, 375:82-86.
4. Ajith T.A., Abhishek G., Roshny D., Sudheesh N.P. Co-supplementation of single and multi doses of vitamins C and E ameliorates cisplatin-induced acute renal failure in mice. Exp. Toxicol. Pathol. 2009, 61:565-571.
5. Augusti P.R., Conterato G.M., Somacal S., Sobieski R., Spohr P.R., Torres J.V., Charão M.F., Moro A.M., Rocha M.P., Garcia S.C., Emanuelli T. Effect of astaxanthin on kidney function impairment and oxidative stress induced by mercuric chloride in rats. Food Chem. Toxicol. 2008, 46:212-219.
6. Beauchamp C., Fridovich I. Superoxide dismutase: improved assays and an assay applicable to acrylamide gel. Anal. Biochem. 1971, 44:276-287.
7. Bergen P.J., Li J., Rayner C.R., Nation R.L. Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 2006, 50:1953-1958.
8. Bradford M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dyes binding. Anal. Biochem. 1976, 72:248-254.
9. Choi H.D., Kim J.H., Chang M.J., Kyu-Youn Y., Shin W.G. Effects of astaxanthin on oxidative stress in overweight and obese adults. Phytother. Res. 2011, 25:1813-1818.
10. Cuzzocrea S., Mazzon E., Dugo L., Serraino I., Paola R.D., Britti D., Sarro A.D., Pierpaoli S., Caputi A.P., Masini E., Salvemini D. A role for superoxide in gentamicin-mediated nephropathy in rats. Eur. J. Pharmacol. 2002, 450:66-67.
11. Dean R.T., Hunt J.V., Grant A.J., Yamamoto Y., Niki E. Free radical damage to proteins: the influence of the relative localization of radical generation, antioxidants and the target proteins. Free Radic. Biol. Med. 1991, 11:161-168.
12. Draper H.H., Hadley M. Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol. 1990, 86:421-431.
13. Ellman G.L. Tissue sulfhydryl groups. Anal. Biochem. 1959, 82:70-77.
14. Falagas M.E., Kasiakou S.K. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin. Infect. Dis. 2005, 40:1333-1341.
15. Falagas M.E., Kasiakou S.K. Toxicity of polymyxins: a systematic review of the evidence from old and recent studies. Crit. Care 2006, 10:R27.
16. Flohe L., Gunzler W.A. Assays of glutathione peroxidase. Methods Enzymol. 1984, 105:114-121.
17. Ghlissi Z., Hakim A., Mnif H., Makni A.F., Zeghal K., Rebai T., Sahnoun Z. Evaluation of colistin nephrotoxicity administered at different doses in the rat model. Ren. Fail. 2013, 35:1130-1135.
18. Guerra B.A., Bolin A.P., Otton R. Carbonyl stress and a combination of astaxanthin/vitamin C induce biochemical changes in human neutrophils. Toxicol. in Vitro 2012, 26:1181-1190.
19. Hakim A., Kallel H., Sahnoun Z., Badraoui R., Jammoussi K., Bouaziz M., Zeghal K.M., Rebaii T. Lack of nephrotoxicity following 15-day therapy with high doses of colistin in rats. Med. Sci. Monit. 2008, 14:74-77.
20. Halliwell B., Gutteridge G.M. Antioxidants Defenses, Free Radical in Biology and Medicines 1999, 105-245. Oxford University, New York. 3rd ed.
21. Hartzell J.D., Neff R., Ake J., Howard R., Olson S., Paolino K., Vishnepolsky M., Weintrob A., Wortmann G. Nephrotoxicity associated with intravenous colistin (colistimethate sodium) treatment at a tertiary care medical center. Clin. Infect. Dis. 2009, 48:1724-1728.
22. Ikeuchi M., Koyama T., Takahashi J., Yazawa K. Effects of astaxanthin supplementation on exercise-induced fatigue in mice. Biol. Pharm. Bull. 2006, 29:2106-2110.
23. Jollow D.J., Mitchell J.R., Zampaglione N., Gillete J.R. Bromobenzene induced liver necrosis: protective role of glutathione and evidence for 3,4-bromobenzeneoxide as the hepatotoxic intermediate. Pharmacology 1974, 1:151-169.
24. Kadkhodaee M., Khastar H., Faghihi M., Ghaznavi R., Zahmatkesh M. Effects of co-supplementation of vitamins E and C on gentamicin-induced nephrotoxicity in rat. Exp. Physiol. 2005, 90:571-576.
25. Kidd P. Astaxanthin, cell membrane nutrient with diverse clinical benefits and anti-aging potential. Altern. Med. Rev. 2011, 16:355-364.
26. Kurashige M., Okimasu E., Inoue M., Utsumi K. Inhibition of oxidative injury of biological membranes by astaxanthin. Physiol. Chem. Phys. Med. 1990, 22:27-38.
27. Li J., Milne R.W., Nation R.L., Turnidge J.D., Smeaton T.C., Coulthard K. Colistin: the re-emerging antibiotic for multidrug-resistant gram-negative bacterial infections. Lancet Infect. Dis. 2006, 6:589-601.
28. Lopez-Novoa J.M., Quiros Y., Vicente L., Morales A.I., Lopez-Hernandez F.J. New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view. Kidney Int. 2011, 79:33-45.
29. Mardones P., Strobel P., Miranda S., Leighton F., Quinones V., Amigo L., Rozowski J., Krieger M., Rigotti A. α-Tocopherol metabolism is abnormal in scavenger receptor class B type I (SR-BI)-deficient mice. J. Nutr. 2002, 132:443-449.
30. McNulty H.P., Byun J., Lockwood S.F., Jacob R.F., Mason R.P. Differential effects of carotenoids on lipid peroxidation due to membrane interactions. X-ray Diffr. Anal. 2007, 1768:167-174.
31. Michalopoulos A.S., Falagas M.E. Colistin and polymyxin B in critical care. Crit. Care Clin. 2008, 24:377-391.
32. Naghibi B., Ghafghazi T., Hajhashemi V., Talebi A., Taheri D. The effect of vitamin E in prevention of vancomycin-induced nephrotoxicity in rats. Res. Pharm. Sci. 2006, 2:104-111.
33. Nakano M., Onodera A., Saito E., Tanabe M., Yajima K., Takahashi J., Nguyen V.C. Effect of astaxanthin in combination with alpha-tocopherol or ascorbic acid against oxidative damage in diabetic ODS rats. J. Nutr. Sci. Vitaminol. (Tokyo) 2008, 54:329-334.
34. Naito Y., Uchiyama K., Aoi W., Hasegawa G., Nakamura N., Yoshida N., Maoka T., Takahashi J., Yoshikawa T. Prevention of diabetic nephropathy by treatment with astaxanthin in diabetic db/db mice. Biofactors 2004, 20:49-59.
35. Ozyilmaz E., Ebinc F.A., Derici U., Gulbahar O., Goktas G., Elmas C., Oguzulgen I.K., Sindel S. Could nephrotoxicity due to colistin be ameliorated with the use of N-acetylcysteine?. Intensive Care Med. 2010, 37:141-146.
36. Pashkow F.J., Watumull D.G., Campbell C.L. Astaxanthin: a novel potential treatment for oxidative stress and inflammation in cardiovascular disease. Am. J. Cardiol. 2008, 101:58-68.
37. Sila A., Nasri M., Bougatef A. Isolation and characterisation of carotenoproteins from deep-water pink shrimp processing waste. Int. J. Biol. Macromol. 2012, 51:953-959.
38. Walker P.D., Barri Y., Shah S.V. Oxidant mechanisms in gentamicin nephrotoxicity. Ren. Fail. 1999, 21:433-442.
39. Yousef J.M., Chen G., Hill P.A., Nation R.L., Li J. Ascorbic acid protects against the nephrotoxicity and apoptosis caused by colistin and affects its pharmacokinetics. J. Antimicrob. Chemother. 2012, 67:452-459.
40. Yousef J.M., Chen G., Hill P.A., Nation R.L., Li J. Melatonin attenuates colistin-induced nephrotoxicity in rats. Antimicrob. Agents Chemother. 2011, 55:4044-4049.